Skip to main content
. Author manuscript; available in PMC: 2024 Apr 15.
Published in final edited form as: Psychopharmacology (Berl). 2020 May 22;237(8):2367–2380. doi: 10.1007/s00213-020-05540-w

Fig. 6.

Fig. 6

Biweekly ratings of anxiety and depression. Data are mean ± SEM. a Effect of pioglitazone on biweekly anxiety ratings (pioglitazone: n = 5; placebo: n = 8). Covariates in the model included baseline CPRS anxiety and baseline PACS craving score. b Effect of pioglitazone on biweekly depression ratings (pioglitazone: n = 5; placebo: n = 8). Covariates in the model included ADS score, baseline CPRS depression, and baseline PACS craving score. For detailed statistics, see “Results